Price
Financials
Standalone, Rs crore| Mar 2018 | Sep 2018 | Mar 2019 | |
|---|---|---|---|
| Revenue from operations | 0.22 | 0.16 | 0.18 |
| Operating costs | 0.45 | 0.24 | 0.42 |
| EBITDA | -0.23 | -0.08 | -0.24 |
| EBITDA margin % | -104.55% | -50.00% | -133.33% |
| Depreciation & amortisation | 0.02 | 0.00 | 0.00 |
| Finance costs | 0.04 | 0.00 | 0.01 |
| Non-operating income | 0.00 | 0.00 | 0.00 |
| Pre-tax profit | -0.29 | -0.08 | -0.25 |
| Effective tax rate % | 0.00% | 0.00% | 0.00% |
| Profit after tax | -0.29 | -0.08 | -0.25 |
| Earnings per share (Rs) | -0.41 | -0.11 | -0.35 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Revenue from operations | 2.24 | 0.51 | 0.34 | 0.00 | 0.00 | 0.00 |
| Operating costs | 2.04 | 0.74 | 0.67 | 0.02 | 0.01 | 0.07 |
| EBITDA | 0.20 | -0.23 | -0.33 | -0.02 | -0.01 | -0.07 |
| EBITDA margin % | 8.93% | -45.10% | -97.06% | |||
| Depreciation & amortisation | 0.07 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Finance costs | 0.00 | 0.05 | 0.01 | 0.00 | 0.00 | 0.00 |
| Non-operating income | -0.01 | 0.04 | 0.00 | 0.00 | 0.00 | 0.01 |
| Pre-tax profit | 0.12 | -0.28 | -0.34 | -0.02 | -0.01 | -0.06 |
| Effective tax rate % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Profit after tax | 0.12 | -0.29 | -0.34 | -0.02 | -0.01 | -0.06 |
| Earnings per share (Rs) | 99.17 | -0.41 | -0.48 | -0.03 | -0.01 | -0.08 |
| Paid out as dividend % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Revenue CAGR | % | % | % | % | ||
| Profit CAGR | % | 13% | % | -500% | ||
| Share price CAGR | % | % | % | % | ||
| Average return on equity | % | % | 0% | -1% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Net block (property, plant) | 0.23 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Capital work in progress | 2.48 | 3.54 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current & other assets | 1.02 | 7.80 | 7.64 | 7.71 | 7.71 | 7.68 |
| Total assets | 3.73 | 11.53 | 7.83 | 7.90 | 7.90 | 7.87 |
| Share capital | 0.01 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 |
| Reserves & surplus | 0.47 | 4.03 | 0.15 | 0.28 | 0.27 | 0.22 |
| Total debt | 0.60 | 0.30 | 0.37 | 0.26 | 0.26 | 0.26 |
| Other liabilities & provisions | 2.65 | 0.11 | 0.22 | 0.27 | 0.28 | 0.30 |
| Equity + liabilities | 3.73 | 11.53 | 7.83 | 7.90 | 7.90 | 7.87 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Operating cash flow | 2.27 | -9.49 | -0.12 | 0.00 | 0.00 | 0.00 |
| Investing cash flow | -2.49 | -1.08 | -0.01 | 0.00 | 0.00 | 0.00 |
| Free cash flow (after capex) | -0.23 | -10.55 | -0.12 | 0.00 | 0.00 | 0.00 |
| Financing cash flow | 0.60 | 10.37 | 0.06 | 0.00 | 0.00 | 0.00 |
| Net change in cash | 0.38 | -0.20 | -0.07 | 0.00 | 0.00 | 0.01 |
| Cash conversion (OCF / EBITDA) % | 1,135% | 4,126% | 36% | 0% | 0% | 0% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|
| Return on capital employed % | -3.68% | -3.47% | -0.13% | -0.79% | ||
| Receivable days | 34.22 | 157.45 | 236.18 | |||
| Inventory days | ||||||
| Payable days | ||||||
| Cash cycle (days) | 34.22 | 157.45 | 236.18 | |||
| Working capital days | -439.96 | 4,959.71 | 7,128.24 |
| Dec 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter group % | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% | 55.41% |
| Foreign investors % | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.34% | 0.00% |
| Domestic institutions % | 0.00% | 21.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retail & others % | 44.25% | 22.42% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.24% | 44.58% |
| Shareholder count | 96 | 96 | 93 | 93 | 93 | 93 | 93 | 93 | 93 | 93 | 93 | 92 |
Fundamentals
Market value₹ 5.66 Cr.
Last price₹ 7.98
Book value / share₹ 10.3
Return on capital-0.79 %
Return on equity-0.82 %
Dividend yield0.00 %
Face value₹ 10.0
Revenue CAGR (TTM)%
Profit CAGR (TTM)-500%
Standalone figures.
Profitability
Operating margin (excl. other income)-45.10%
Operating margin (incl. other income)-37.25%
EBITDA margin-37.25%
Pre-tax margin-54.90%
Net profit margin-56.86%
ROE-5.00%
ROCE-3.68%
ROA-3.80%
ROIC (approx.)-2.06%
Other income / net worth0.36%
Growth
Sales growth (latest year)-77.23%
Profit growth (latest year)-341.67%
Per share
EPS (TTM)Rs -0.41
EPS (latest year)Rs -0.41
Book value per shareRs 15.68
Sales per shareRs 0.72
Cash flow per shareRs -13.38
Efficiency
Asset turnover0.04x
Fixed asset turnover2.68x
Inventory turnover0.50x
Inventory days730 days
Debtor days157 days
Debtors turnover2.32x
Leverage
Total debtRs 0 Cr
Cash and bankRs 0 Cr
Net debtRs 0 Cr
Debt to equity0.03x
Interest coverage-4.60x
Owners' fund to total sources96.44%
Debt to assets2.60%
Cash flow
Operating cash flow (latest year)Rs -9 Cr
Investing cash flow (latest year)Rs -1 Cr
Financing cash flow (latest year)Rs 10 Cr
Net change in cash (latest year)Rs -0 Cr
Statement figures
Net sales (TTM)Rs 1 Cr
Net sales (latest year)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs -0 Cr
Depreciation (TTM)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 1 Cr
Total income (latest year)Rs 1 Cr
Share capitalRs 7 Cr
ReservesRs 4 Cr
Shareholders' fundsRs 11 Cr
Total assetsRs 12 Cr
Net blockRs 0 Cr
Capital work in progressRs 4 Cr
ReceivablesRs 0 Cr
InventoryRs 0 Cr
Other liabilitiesRs 0 Cr
Shares outstanding (crore)0.71
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 2 of 8| explain | High accruals Profit exceeded operating cash by 80% of total assets in 2024 |
| explain | Receivables outrunning sales Receivables grew 5% vs sales -77% in 2024 |
| look | Inventory outrunning sales Inventory grew -5% vs sales -77% in 2024 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Kids Medical Systems Ltd?
Kids Medical Systems Ltd (540812) has a market capitalisation of Rs 5.66 Cr. at the close.